The Ayurveda Co Secures $12.2 Million in Series A Funding
Consumer-Centric Fund Sixth Sense Ventures Leads Investment Round
The Ayurveda Co, a prominent direct-to-consumer brand, has successfully raised $12.2 million (approximately Rs 100 crore) in a Series A funding round.
Sixth Sense Ventures, a consumer-centric fund, led the investment, with participation from notable figures including actress Kajal Agarwal, startup founders, and venture debts.
Investment Allocation and Expansion Plans
The newly acquired funds are earmarked for various strategic initiatives. The Ayurveda Co intends to enhance its product manufacturing capabilities, allocate resources to research and development efforts,
and bolster its offline presence. Additionally, a portion of the investment will be directed towards the development and launch of an Ayurveda-centric mobile application, slated for release by mid-2023.
Company Background and Product Offerings
Founded in 2020 by Shreedha Singh and Param Bhargava, The Ayurveda Co specializes in offering a wide range of Ayurveda-based products spanning the face, skin, and hair segments.
The company boasts a dedicated team of over 60 individuals and has successfully catered to the needs of over a lakh customers, selling more than two lakh units of its products.
Furthermore, The Ayurveda Co operates 20 brand outlets and has established a robust retail presence, with its products available in over 5,000 retail stores nationwide.
OmniBRx Biotechnologies Raises Rs 30 Crore in Series A Funding
SIDBI Venture Capital Invests in Bioprocess Engineering Company
OmniBRx Biotechnologies, a leading bioprocess engineering firm, has secured Rs 30 crore in a Series A funding round from SIDBI Venture Capital. This infusion of capital will facilitate OmniBRx’s expansion into international markets and support initiatives aimed at augmenting manufacturing capabilities and capacity addition.
Strategic Vision and Unique Offerings
OmniBRx Biotechnologies, headquartered in Delhi, boasts cutting-edge technology and innovative solutions in the bioprocess engineering domain.
The company’s flagship product, the CellBRx Single-use Bioreactors,stands as the world’s largest and most efficient platform for vaccine manufacturing and viral vector production.
Additionally, OmniBRx has pioneered the development of integrated seed train development platforms, setting new benchmarks in bioreactor system efficiency.
Raaho Secures Rs 20 Crore in Pre-Series A Extension Round
Existing Investors Lead Funding, Valuation Soars 4X
Trucking marketplace Raaho has successfully raised Rs 20 crore in an extension to its pre-Series A funding round.
The investment was spearheaded by existing investors, including Inflection Point Ventures, Roots Ventures, Blume Founders Fund, and a cadre of angel investors such as Vijay Shekhar Sharma and Kunal Shah.
This additional capital infusion has propelled Raaho’s valuation to Rs 396 crore, marking a significant increase over the past year.
Expansion and Technological Advancements
With the fresh influx of funds, Raaho aims to penetrate new markets across India and fortify its data science and machine learning capabilities. Presently operational in over 15 Indian cities,
including major hubs like the National Capital Region, Bengaluru, and Mumbai, Raaho is poised for further growth and expansion in the logistics sector.
This trio of funding rounds underscores the continued vibrancy and investment potential within the startup ecosystem, particularly in sectors such as healthcare, biotechnology, and logistics.
As these companies embark on their growth trajectories, they are poised to make significant contributions to their respective industries, driving innovation and creating value in the process.
Read
More On: Thestartupscoup.Com
